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SUMMARY 
Temperatures i n  t h e  range 41.5OC t o  43.5OC tend  t o  b e  more damaging t o  
malignant t han  nonmalignant c e l l s .  Where l o c a l  hyperthermia (41. ~ O C  t o  43.5'~) 
i s  combined wi th  i o n i z i n g  r a d i a t i o n ,  a  s i g n i f i c a n t  t h e r a p e u t i c  r a t i o  may b e  
r e a l i z e d .  T o t a l  body hyperthermia, a lone  o r  combined wi th  o t h e r  t h e r a p e u t i c  
moda l i t i e s ,  can provide  p a l l i a t i o n  f o r  some systemic malignancies  bu t  may no t  
be as e f f e c t i v e  a s  l o c a l  hyperthermia f o r  t r e a t i n g  l o c a l  d i sease .  The i n f l u -  
ence of hyperthermia on immune mechanisms and t h e  r i s k  of m e t a s t a t i c  spread 
of p o t e n t i a l  tumor growth s t i m u l a t i o n  need f u r t h e r  i n v e s t i g a t i o n .  Among o t h e r  
ques t ions  needing e l u c i d a t i o n  be fo re  hyperthermia can b e  considered a  s tandard  
t reatment  modal i ty  a r e  t h e  time-dose ( f o r  hea t ing )  r e l a t i o n s h i p s  t o  produce an 
opt imal  t h e r a p e u t i c  r a t i o  and whether t h e  l a t e  sequela  of combined hea t  and 
ion iz ing  r a d i a t i o n  may r e s u l t  i n  an unacceptable  r i s k  of p a t i e n t  morbidi ty .  
INTRODUCTION 
Radia t ion  therapy  may f a i l  t o  achieve  l o c a l  c o n t r o l  of a  cancer  e i t h e r  
because of geographic m i s s  o r  because of i n s u f f i c i e n t  t o t a l  dose o r  time-dose, 
o r  both.  I n  t h e  l a t t e r  case ,  i t  may n o t  be  p o s s i b l e  t o  d e l i v e r  a  dose of 
r a d i a t i o n  l a r g e  enough t o  s t e r i l i z e  a l l  t h e  clonogenic c e l l s  because some 
c r i t i c a l  organ i n  t h e  t r e a t e d  volume, e .g . ,  s p i n a l  cord,  w i l l  r e c e i v e  an 
i n t o l e r a b l e  dose. Another p o s s i b l e  r ea son  f o r  l o c a l  f a i l u r e  is  t h e  presence  
of hypoxic f o c i  of tumor c e l l s  whose low r a d i o s e r ~ s i t i v i t y  r e s u l t s  i n  a  
s i g n i f i c a n t  number of surv iv ing  c e l l s  when t h e  t o l e r a n c e  dose has  been de- 
l i v e r e d .  Another c o n t r i b u t i n g  f a c t o r  could b e  t h e  inhe ren t  capac i ty  of c e l l s  
from tumors of c e r t a i n  h i s t o l o g i e s  t o  r e p a i r  a  l a r g e  propor t ion  of r a d i a t i o n  
i n j u r y  fo l lowing  each d a i l y  f r a c t i o n ,  A number of schemes have t h e r e f o r e  
been evolved e i t h e r  t o  i n c r e a s e  t h e  r a d i a t i o n  s e n s i t i v i t y  of t h e  tumor c e l l s  
o r  t o  dec rease  t h e  s e n s i t i v i t y  of t h e  normal t i s s u e s  i n  t h e  i r r a d i a t e d  volume, 
Hyperthermia is  a  technique  which has  p o t e n t i a l  f o r  i nc reas ing  t h e  the rapeu t i c  
r a t i o  by i n c r e a s i n g  t h e  r a d i o s e n s i t i v i t y  of tumor c e l l s .  
Hippocrates  descr ibed  a t  l eng th  t h e  b e n e f i c i a l  e f f e c t s  of hea t  and ho t  
ba ths  i n  main ta in ing  good h e a l t h  and a s  a t h e r a p e u t i c  regimen f o r  many d i s e a s e s ,  
It is  i n t e r e s t i n g  t o  s p e c u l a t e  whether i n  Japan, f o r  example, where many people 
t a k e  d a i l y  ho t  ba ths ,  t h e r e  is a  connect ion between t h i s  p r a c t i c e  and t h e  f a c t  
t h a t  t h e  n a t i o n a l  inc idence  of b r e a s t ,  p e n i l e ,  t e s t i c u l a r ,  and s k i n  cancers  i s  
among t h e  lowest  i n  t h e  world, The temperature of t h e s e  b a t h s  ranges from 
42OC t o  4 8 O ~  and r e s u l t s  i n  r e c t a l  temperatures  of  approximately 3g°C. (See 
r e f .  1.)  I n  F in land ,  where sauna ba th ing  i s  p r a c t i c e d ,  t h e  inc idence  of 
t e s t i c u l a r  and mammary cancer  i s  lower than  i n  neighboring c o u n t r i e s  where t h e  
sauna i s  n o t  used. (See r e f .  2.)  
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For many y e a r s  t h e r e  have been c l i n i c a l  r e p o r t s  i n d i c a t i n g  t h a t  h e a t  h a s  
a  s e l e c t i v e l y  d e s t r u c t i v e  e f f e c t  on cancer  c e l l s  i n  v ivo  i n  comparison w i t h  
-- 
surrounding normal t i s s u e s .  
Some e a r l y  c l i n i c a l  r e p o r t s  reviewed by Selawry, -- e t  ala ( r e f .  3) and 
Caval ie re  -- e t  a 1  ( r e f .  4 )  i nc lude  an  1866 account desc r ib ing  h i s t o l o g i c a l l y  
proven sarcoma of t h e  f a c e  which regressed  a f t e r  h igh  f eve r  a s s o c i a t e d  w i t h  
s y p h i l i s .  The reviewers  a l s o  mentioned a  d i scuss ion  by Coley -- e t  a 1  ( r e f .  5) 
of 38 p a t i e n t s  wi th  advanced carcinoma who had an a s s o c i a t i o n  wi th  a c c i d e n t a l  
o r  d e l i b e r a t e  i n f e c t i o n s .  I n  t h i s  s e r i e s  t h e r e  was complete disappearance 
of t h e  tumors i n  12 ca ses ,  and a  s i g n i f i c a n t  r e g r e s s i o n  i n  19 cases .  A 
d e t a i l e d  review of t h i s  s tudy  was done by Nauts -- e t  a l . ( r e f .  6 ) .  
I n  V i t r o  S tud ie s  
When popula t ion  of c e l l s  a r e  exposed t o  a  s e r i e s  of graded doses of X-rays 
and t h e  percentage of su rv iv ing  c e l l s  counted, t h e  p l o t  of su rv iv ing  f r a c t i o n  
(S) on a  log  s c a l e  a g a i n s t  dose on a l i n e a r  s c a l e  y i e l d s  a  dose-ef fec t  
r e l a t i o n s h i p  cha rac t e r i zed  by an  i n i t i a l  shoulder  reg ion  a t  low doses and 
an  exponent ia l  r eg ion  a t  h igher  doses.  
The parameters of t h i s  r e l a t i o n s h i p ,  Do, Dq, and n ,  can be  used t o  d e f i n e  
t h e  r a d i o s e n s i t i v i t y  of t h e  c e l l s  a s  an e s t i m a t e  of t h e i r  capac i ty  t o  r e p a i r  
r a d i a t i o n  i n j u r y .  (See f i g .  1 . )  
I f  c e l l  popula t ions  a r e  incubated a t  e l eva t ed  temperatures  f o r  d i f f e r -  
e n t  pe r iods  of t ime, t h e  p ropor t ion  of c e l l s  su rv iv ing  t h e  hyperthermia 
may be  descr ibed  by us ing  a  n o t a t i o n  s i m i l a r  t o  t h a t  used f o r  s u r v i v a l  a f t e r  
X-radiation. 
Figure 2 ,  taken from r e p o r t  by Henle and Leeper ( r e f .  7) ,  i l l u s t r a t e s  t h e  
response of c e l l s  e i t h e r  t o  X-ray o r  hyperthermia. The s i m i l a r i t i e s  i n  shape 
of t h e  dose-response r e l a t i o n s h i p s  do no t  imply common mechanism of a c t i o n ,  
and c a r e  must be  exe rc i sed  n o t  t o  draw unwarranted conclus ions  by g iv ing  t h e  
s u r v i v a l  c h a r a c t e r i s t i c s  t h e  same i n t e r p r e t a t i o n  f o r  hyperthermia as f o r  
X-ray. 
An example of t h e  p o t e n t i a t i n g  e f f e c t  of hyperthermia on t h e  r a d i a t i o n  
response of CHO c e l l s  i s  shown i n  f i g u r e  3 taken from a r e p o r t  by Gerner 
( r e f ,  8 ) .  On t h e  r i g h t  s i d e  of t h e  f i g u r e  i s  shown t h e  e f f e c t  of i ncuba t ing  
t h e  c e l l s  a t  temperatures  up t o  43OC f o r  1 hour be fo re  t h e  X-radiation. The 
s o l i d  c i r c l e s  (upper curve) show t h e  response t o  r a d i a t i o n  a t  a  normal 
phys io log ica l  temperature,  37OC. Note t h a t  i nc reas ing  t h e  incuba t ion  
temperature up t o  43%C, a  tempera ture  which by i t s e l f  decreased c e l l  s u r v i v a l  
t o  20 pe r  c e n t ,  causes  a  dramatic  i n c r e a s e  i n  r a d i o s e n s i t i v i t y ,  i .e . ,  by a  
f a c t o r  of 2. 
A s  i n  many new i n v e s t i g a t i v e  procedures ,  r e s e a r c h e r s  have adopted a  
t e c h n i c a l  jargon.  One such express ion  is  t h e  thermal  enhancement r a t i o  o r  
TER. Th i s  is  g e n e r a l l y  t h e  r a t i o  of a  dose of X-ray o r  drug requi red  t o  
e l i c i t  a  given e f f e c t ,  compared w i t h  t h e  dose of t h e  same agent  r equ i r ed  t o  
g ive  t h e  i d e n t i c a l  e f f e c t  when combined w i t h  hyperthermia. 
The term can a l s o  b e  used t o  i n d i c a t e  t h e  r a t i o  of t h e  s lopes  of t h e  
exponent ia l  p o r t i o n s  of t h e  dose-response curves  when t h e  r e l a t i o n s h i p s  a r e  
determined w i t h  and without  hyperthermia. It can be  considered a s  analogous t o  
t h e  express ions  "dose-modifying f a c t o r s  (DMF)" o r  OER commonly used i n  
r a d i a t i o n  biology.  
I n  t h e  example j u s t  s t a t e d ,  t h e  thermal  enhancement r a t i o  would be  
ind ica t ed  a s  TER 43/1 hr. = = 2.2. 
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I n  t h i s  system, t h e  p o s t - i r r a d i a t i o n  h e a t i n g  d i d  not  r e s u l t  i n  a  TER 
s i g n i f i c a n t l y  d i f f e r e n t  from t h a t  found w i t h  p r e - i r r a d i a t i o n  hyperthermia. 
A t  temperatures  between 41,5OC and 43Oc, a  number of systems show tumor 
c e l l s  t o  b e  more s e n s i t i v e  t o  thermal  i n j u r y  than a r e  t h e  normal c e l l s  of t h e  
same o r i g i n .  Figure 4 ,  taken from a  r e p o r t  by Giovanella e t  a l A ( r e f .  9) i s  
r e p r e s e n t a t i v e  of a  l a r g e  body of information i n d i c a t i n g  t h i s  d i f f e r e n t i a l  
thermal s e n s i t i v i t y .  The optimum t h e r a p e u t i c  advantage probably w i l l  be  
obtained wi th  hyperthermia i n  t h e  range of 41.5OC t o  4 3 ' ~  and t h a t  t h e  d i f -  
f e r e n t i a l  e f f e c t  between tumor and normal c e l l s  may diminish a t  h igher  
temperatures .  
Thermodynamics cons ide ra t ions  suggest  t h e  p o s s i b i l i t y  t h a t  temperatures  
s l i g h t l y  i n  excess  of 3 7 ' ~  might prove s t i rnulatory t o  tumor c e l l  growth. 
Some i n  v i t r o  s t u d i e s  tend t o  support  t h i s  cond i t i on  ( r e f s .  10, 11, and 12) .  
Above 4 1 . 5 ' ~  a  c o n s i s t e n t  i n h i b i t o r y  e f f e c t  can be  demonstrated. I n  appl ica-  
t i o n s  of hyperthermia t o  c l i n i c a l  oncology ( t a b l e  l ) ,  temperatures  
between 41.5OC and 43.0°C a r e  thought t o  be opt imal  f o r  d i f f e r e n t i a l l y  sens i -  
t i z i n g  tumor c e l l s  t o  damage by i o n i z i n g  r a d i a t i o n .  
I n  some systems t h e  e f f e c t s  of combined X-ray and hyperthermia on c e l l  
s u r v i v a l  a r e  inf luenced  by t h e  sequence i n  which t h e  t rea tments  a r e  appl ied .  
Gerner -- e t  a l .  ( r e f .  13) found a  s l i g h t l y  increased  thermal enhancement of 
r a d i a t i o n  damage of CHO c e l l s  heated (one hour a t  43OC) immediately a f t e r  
i r r a d i a t i o n ,  bu t  noted an oppos i t e  response f o r  HeLa c e l l s .  Van d e r  Schueren 
1975 ( r e f .  14) ,  us ing  a  c e l l  l i n e  der ived  from u r e t e r a l  t i s s u e ,  found a  g r e a t e r  
thermal enhancement of c e l l  k i l l  by h e a t i n g  nea r  t h e  end o f ,  o r  immediately 
fol lowing,  exposure t o  X-radiation. 
Sapare ta  -- e t  a l .1976 ( r e f .  15) compared t h e  e f f e c t  of hea t ing  ( 4 2 . 5 ' ~  o r  
45.5OC) CHO c e l l s  dur ing  and up t o  120 minutes be fo re  o r  a f t e r  a  500 r ad  dose 
of X-radiat ion.  The d a t a  c l e a r l y  showed t h a t  t h e  p o t e n t i a t i n g  e f f e c t  of hea t  
on c e l l  d e a t h  w a s  g r e a t e s t  when t h e  r a d i a t i o n  was de l ive red  e a r l y  dur ing  t h e  
hea t ing  i n t e r v a l .  There was a  r ap id  l o s s  of thermal  e f f e c t  i f  t h e  r a d i a t i o n  
was given a f t e r  t h e  hea t ing .  Using r a d i a t i o n  damage t o  mouse s k i n  a s  t h e  
c r i t e r i a  of response,  F i e l d  -- e t  a l . ( r e f .  16) found t h a t  hea t ing  ( 4 2 ' ~  o r  4 3 ' ~  
f o r  1 hour) a t  i n t e r v a l s  up t o  2 hours be fo re  X-radiation y i e lded  a  s i g n i f i c a n t  
thermal enhancement. The thermal  enhancement was l o s t  r a p i d l y  i f '  t h e  h e a t  was 
given a f t e r  t h e  i r r a d i a t i o n .  
G i l l e t t e  and T h r a l l  i n  1975 ( r e f .  17) found thermal p o t e n t i a t i o n  of X-ray 
damage t o  mouse mammary carcinoma t o  be h i g h e s t  when t h e  h e a t  was app l i ed  
immediately a f t e r  i r r a d i a t i o n .  Based on ex tens ive  c l i n i c a l  experience,  Hol t  
( r e f .  18) concluded t h a t  t h e  TER is  maximum when t h e  hyperthermia was d e l i v e r e d  
be fo re  t h e  i r r a d i a t i o n .  Overgaard and Overgaard ( r e f .  19) using a s o l i d  tumor 
i n  mice f i n d  t h a t  t h e  p o t e n t i a t i n g  e f f e c t  of hyperthermia on t h e  response of 
t h e  tumor t o  X-radiation w a s  independent of t h e  sequence i n  which t h e  t rea tment  
were appl ied  up t o  an  i n t e r v a l  of 24 hours.  
It seems reasonable  t o  assume t h a t  t h e  maximum p o t e n t i a t i o n  of r a d i a t i o n  
damage by hyperthermia would occur when t h e  i n t e r v a l  between t rea tments  was 
sho r t .  I n  t h e  a p p l i c a t i o n  of hyperthermia t o  c l i n i c a l  r a d i a t i o n  oncology, t h e  
sequence w i l l  probably be determined by t h e  t rea tment  l o g i s t i c s  of t h e  depar t -  
ment a t  l e a s t  u n t i l  t h e  b a s i s  of s e l e c t i n g  one sequence over  another  i s  more 
c l e a r l y  ev ident .  The express ion  of thermal damage i s  no t  l i m i t e d  t o  t h e  
p o t e n t i a t i o n  of X-ray responses.  F igure  5 ( r e f .  19) shows t h e  i n t e r a c t i o n  of 
hyperthermia and drugs when temperatures  of 42OC produce very  l a r g e  decreases  
i n  c e l l  s u r v i v a l .  F igure  6 ( r e f .  20) shows t h e  response of popula t ion  of tumor 
c e l l s  which were t r e a t e d  -- i n  v ivo  b u t  assayed i n  v i t r o .  These d a t a  i n d i c a t e  
-- 
t h a t  both -- i n  v ivo  and i n  v i t r o  hyperthermia enhances t h e  e f f e c t i v e n e s s  of 
-- 
t h e s e  c y t o t o x i c  agents .  
There a r e  no d a t a  a v a i l a b l e  a t  t h i s  t ime showing t h e  e f f e c t  of mult idrug 
chemotherapy and hyperthermia. Such s t u d i e s  might y i e l d  va luab le  information.  
Before t h e  p o t e n t i a t i n g  a c t i o n  of hyperthermia can be  exp lo i t ed  as p a r t  
of a t h e r a p e u t i c  regimen, i t  is  necessary  t o  e s t a b l i s h  whether a s i g n i f i c a n t  
t h e r a p e u t i c  r a t i o  can be achieved. 
The t h e r a p e u t i c  r a t i o  i s  e s s e n t i a l l y  a cos t -benef i t  assessment ,  F igure  7 
i l l u s t r a t e s  t h i s  r e l a t i o n s h i p .  It i s  determined by e s t ima t ing  t h e  damage 
done t o  t h e  tumor, i . e . ,  r e g r e s s i o n  i n  s i z e  o r  p a l l i a t i o n  of symptoms compared 
wi th  t h e  damage done t o  t h e  normal t i s s u e s  i n  t h e  i r r a d i a t e d  volume. 
Table 2,  based on t h e  work of Robinson i n  Baltimore ( r e f .  21) shows t h a t  
a l though both t h e  TER f o r  tumor and normal t i s s u e s  i nc rease  wi th  temperature,  
t h e  TER f o r  tumors i nc reases  f a s t e r  than  t h a t  f o r  normal t i s s u e  ( s k i n ) .  This  
observa t ion  i n d i c a t e s  t h a t  a s i g n i f i c a n t  t h e r a p e u t i c  r a t i o  can be achieved. 
There a r e  d a t a  i n d i c a t i n g  t h a t  t h e  d i f f e r e n t i a l  s e n s i t i v i t y  of normal and 
tumor c e l l s  is  absent  a t  h igher  temperatures .  
Radiat ion and t h e  Oxygen Ef fec t  
One of t h e  problems confounding t h e  r a d i o t h e r a p i s t  is  t h e  f a c t  t h a t  
hypoxic c e l l s  have a reduced r a d i o s e n s i t i v i t y .  I f  t h e  r a d i o s e n s i t i v i t y  of 
c e l l s  made seve re ly  hypoxic dur ing  i r r a d i a t i o n  i s  compared w i t h  those  f u l l y  
oxygenated, t h e  s e n s i t i v i t i e s  c h a r a c t e r i s t i c a l l y  d i f f e r  by a f a c t o r  of 
between 2 and 3. This  r a t i o  i s  des igna ted  a s  t h e  oxygen enhancement r a t i o  o r  
t h e  OER. In a number of systems, hypoxic c e l l s  have been shown t o  b e  more 
s e n s i t i v e  t o  thermal  i n j u r y  than a r e  t o x i c  c e l l s .  I n  many systems, there-  
f o r e ,  i t  i s  poss ib l e  t o  demonstrate a s i g n i f i c a n t  reduct ion  i n  OER by hyper- 
thermia. This  f a c t  is  p o t e n t i a l l y  of very g r e a t  s ignif ica(nce,  s i n c e  i t  may 
inc rease  the  chance of c o n t r o l  o r  provide p a l l i a t i o n  of bulky l o c a l  d i s e a s e  
which would o therwise  be  impossible ,  This  is  demonstrated by t a b l e  3 taken 
from a r e p o r t  by Robinson ( r e f .  21).  Other i n v e s t i g a t o r s  ( r e f .  22) have a l s o  
observed an  enhanced TER f o r  hypoxic p o l l s .  
Whole Body Hyperthermia 
About 1913, A. A. S t r auss  used surgery  and hyperthermia t o  t r e a t  carcinoma 
of t h e  rectum and colon,  w i th  e x c e l l e n t  r e s u l t s  ( r e f .  23).  By 1956 he had 
t r e a t e d  250 such p a t i e n t s ,  and long-term follow-up ind ica t ed  r e s u l t s  comparable 
wi th ,  o r  s u p e r i o r  t o ,  any therapy then a v a i l a b l e  ( r e f .  24). 
Pe t t i g rew -- e t  a l , ( r e f s .  25 and 26) t r e a t e d  a number of terminal-s tage cancer  
p a t i e n t s  wi th  total-body hyperthermia (41°C t o  42OC) and occas iona l ly  combined 
t h i s  t rea tment  wi th  chemotherapy. I n  a l l  c a ses  t h e  p a t i e n t s  were no longer  
t r e a t a b l e  by convent ional  t h e r a p e u t i c  moda l i t i e s .  For those  t r e a t e d ,  hyper- 
thermia a lone  produced a s i g n i f i c a n t  r eg re s s ion  i n  sarcomas and i n  tumors of 
t h e  g a s t r o - i n t e s t i n a l  t r a c t .  Breast  and geni to-urinary tumors responded poorly.  
A l l  p a t i e n t s  wi th  pa in  o r  b leeding  experienced p a l l i a t i o n  of t h e s e  symptoms. 
Figure 8 taken from a r epor t  by S to lwi jk  ( r e f .  27) shows t h e  probably range of 
temperatures  t h a t  might be t o l e r a t e d  f o r  whole body hyperthermia. It is  
un l ike ly  t h a t  a temperature i n  excess  of 4 3 ' ~  could b e  t o l e r a t e d  f o r  more than  
a few minutes without  s i g n i f i c a n t  r i s k  of s eve re  damage. Most c l i n i c a l  s e r i e s  
0 have t h e r e f o r e  at tempted t o  achieve  a c o r e  temperature i n  t he  razge of 40 C t o  
42.5'~. 
A s  wi th  any therapy whose mechanism of a c t i o n  is  n o t  w e l l  understood 
t h e r e  a r e  many ques t ions  t h a t  remain t o  be  resolved.  It seems l i k e l y  t h a t  
temperatures  only s l i g h t l y  above t h e  normal phys io log ica l  range may s t i m u l a t e  
tumor growth r a t h e r  than  i n h i b i t  i t .  There a r e  some experimental  d a t a  which 
support  t h i s  p o s s i b i l i t y  ( r e f .  28). There i s  some i n d i r e c t  evidence from 
animal s t u d i e s  t h a t  whole body hyperthermia ( t o  4 0 ' ~  temperature e l e v a t i o n )  
may temporar i ly  suppress  immune mechanisms and perhaps p o t e n t i a t e  m e t a s t a t i c  
spread. F igures  9 and 10 taken from a r e p o r t  by Dickson ( r e f .  12) i l l u s t r a t e  
t h i s  concern. Animals s t u d i e s  ( r e f s .  29 and 30) i n d i c a t e  an increased  r i s k  of 
m e t a s t a t i c  spread wi th  whole body hyperthermia. Evidence f o r  an increased  
r i s k  from l o c a l  hyperthermia has no t  been c l e a r l y  demonstrated. The e f f e c t i v e -  
ness  of l o c a l  compared wi th  t o t a l  body hyperthermia i s  i l l u s t r a t e d  by f i g u r e  11 
taken from a r e p o r t  by Dickson and Muckle ( r e f .  30).  This  may not  be  c r i t i c a l  
cons ide ra t ion  i n  p a l l i a t i v e  therapy f o r  systemic d isease .  
Regional Hyperthermia by Per fus ion  
A number of i n v e s t i g a t o r s  have used hyperthermic per fus ion  of e x t r e m i t i e s  
t o  t r e a t  d i s e a s e  when l o c a l  spread was suspected.  The d a t a  i n  t a b l e  4 from 
a r e p o r t  by S t e h l i n  -- e t  a l .  ( r e f .  31) show t h e  r e s u l t s  of hyperthermia pe r fus ion  
on melanoma l e s i o n s  of t h e  e x t r e m i t i e s .  The d a t a  shows hyperthermia r e s u l t e d  
i n  an increased  inc idence  i n  r eg iona l  c o n t r o l  and p a l l i a t i o n  of d i sease .  
Cava l i e r e  -- e t  a l . ( r e f .  4) r epo r t ed  tumor r eg re s s ion  i n  15 of 22 p a t i e n t s  
t r e a t e d  wi th  heated perfused blood f o r  sarcomas and melanomas of t h e  
ex t r emi t i e s .  I n  t h e  Proceedings of t h e  I n t e r n a t i o n a l  Symposium pn Cancer 
Therapy by Hyperthermia and Radia t ion ,  Caval ie re  -- e t  a l ,  ( r e f .  32) reviewed 
t h e i r  experience i n  us ing  hyperthermic pe r fus ion  t o  t r e a t  111 p a t i e n t s  w i t h  
advanced tumors of t h e  ex t r emi t i e s :  5 ,  squamous-cell carcinoma; 27, os teogenic  
sarcoma; 28, o t h e r  sarcomas; and 51, melanoma. I n  some i n s t a n c e s ,  chemothera- 
p e u t i c  agents  were incorpora ted  i n t o  t h e  pe r fusa t e .  Most of t h e s e  p a t i e n t s  
subsequent ly underwent amputation of t h e  a f f e c t e d  limb. ~ l t h o u g h  t h e r e  w a s  a  
v a r i e t y  of temperatures ,  du ra t ions ,  and o t h e r  cond i t i ons ,  t h e r e  was no doubt 
t h a t  i n i t i a l  tumor response and NED s u r v i v a l  f o r  comparable s t a g e s  of c l i n i c a l  
d i s e a s e  t r e a t e d  without  hyperthermia ( h i s t o r i c a l  c o n t r o l s )  were c o n s i s t e n t l y  
improved by t h e  use of hyperthermia. 
H a l l  -- e t  a l , ( r e f .  33) perfused t h e  b ladders  of 32 p a t i e n t s  s u f f e r i n g  fromo 
carcinomas of t h e  u r i n a r y  b ladder  w i th  s o l u t i o n s  a t  temperatures  between 41,5 
and 45 '~.  There w a s  s u b s t a n t i a l  tumor r eg re s s ion  i n  26 of t h e  p a t i e n t s  and 
complete tumor r e g r e s s i o n  i n  4. 
Cockett  -- e t  a 1  ( r e f .  34) r epo r t ed  a  r educ t ion  i n  tumor s i z e  fol lowing l o c a l  
hyperthermia and r e g i o n a l  rad io therapy  i n  7 e l d e r l y  p a t i e n t s  wi th  incu rab le  
carcinomas of t h e  b ladder .  I n  c o n t r a s t ,  Lunglmayr -- e t  a 1  ( r e f .  35) r epo r t ed  
t h a t  l o c a l  hyperthermia combined w i t h  chemotherapy f a i l e d  t o  o f f e r  any sub- 
s t a n t i a l  ga in  i n  t h e  t rea tment  of low s t a g e  v e s i c l e  papillomas because of a  
high r a t e  of complicat ions which followed t h i s  t rea tmect .  
Local Hyperthermia 
Selawry e t  a l , ( r e f .  3) made r e fe rence  t o  more than  30 publ ished c l i n i c a l  
s e r i e s  i n  which a  wide spectrum of tumors were t r e a t e d  by va r ious  combinations 
of X-ray and hyperthermia. A l l  t h e s e  r e p o r t s  noted t h e  p o t e n t i a t i n g  e f f e c t  of 
hyperthermia on r a d i a t i o n  response of t h e  tumor, a l though u n c e r t a i n t i e s  i n  
r a d i a t i o n  dosimetry and temperatures  measurements made more p r e c i s e  comparisons 
of response i m p r a c t i c a l  . 
Hol t  ( r e f .  18) t r e a t e d  p a t i e n t s  by means of a  device  c o n s i s t i n g  of 12 RF 
gene ra to r s  ope ra t ing  a t  433.92 MHz and placed i n  a  c i r c u l a r  con f igu ra t ion ,  
wi th  t h e  p a t i e n t  s i t t i n g  o r  s tanding  i n  t h e  c e n t e r  of t h e  c y l i n d r i c a l  a r r ay .  
For most p a t i e n t s  t h e  RF i r r a d i a t i o n  was combined wi th  X-ray therapy  o r  
chemotherapy. The r e p o r t  i n d i c a t e d  t h a t  363 p a t i e n t s  wi th  advanced d i s e a s e  
were t r e a t e d ,  The au thor  gave no d e t a i l s  concerning t i s s u e  temperatures ,  
du ra t ion  of t h e  radiofrequency t r ea tmen t s ,  o r  i n t e r v a l s  between RF and X-ray 
t rea tments  (H + Rx). He concluded t h a t  RF r a d i a t i o n  produced s i g n i f i c a n t  
enhancement of t h e r a p e u t i c  r a t i o  f o r  p a t i e n t s  r ece iv ing  X-ray therapy.  Hornback 
e t  a l ,  ( r e f ,  36) us ing  a  s i m i l a r  technique  r epor t ed  a  s i g n i f i c a n t  enhancement of 
--
r a d i a t i o n  response f o r  p a t i e n t s  w i t h  a  wide range of malignancies .  
Brenner ( r e f .  37) combined hot  a i r  j e t s  and microwave (2450 mc/sec) t o  
iqduce l o c a l  hyperthermia which they  used wi th  or thovol tage  r a d i a t i o n  t o  achieve  
impressive tumor r eg re s s ion  i n  6 p a t i e n t s .  LeVeen ( r e f .  38) repor ted  a  s e r i e s  
of 21 p a t i e n t s  t r e a t e d  by inducing l o c a l  hyperthermia i n  tumors through use  of 
a  r a d i o  frequency genera tor  opera ted  a t  13.56 MHz. I n  a l l  ca ses  t h e r e  was 
s i g n i f i c a n t  tumor regress ion .  
Johnson (ref, 39) reported results of a pilot clinical trial to assess 
the therapeutic ratio when X-radiation was combined with local hyperthermia to 
treat patients with multiple superficial lesions, i.e., up to 2 cm. in depth. 
The lesions were heated to 41°C to 42.5'~ with 915 MHz microwaves for periods 
of 1% to 2 hours. Heating alone produced no damage to the normal skin. The 
thermal enhancement ratio (TER) for irradiated normal skin was 1.2 to 1.3. 
Heating during and immediately after irradiation produced the maximum response 
of tumor and normal tissues. The data are not yet sufficiently complete to 
make possible an estimate of the therapeutic ratio. 
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TABLE 1. 
39. CP - 41' 0' c 
potential 
41.5 - 43.0'~ 
Differential 
43.5 - 4 6 . 0 ~ ~  
mss of diff- 
Sthulation Thermal damage erential for 
to tuanar cells -damage 
totunnaelLs 
Table - 1 shows the probable useful  range of temperatures for  tumor sens i t izat ion 
i n  therapeutic oncology. 
TABLE 2. 
TEMP. SKIN RESPONSE TUMOR RESPONSE TUMOR T.E.R. 
("C) T.E.D.so.I. T.E.R." T.C.D.sov0 T.E.R." SKIN T.E.R. 
(rads) (rads) 
37.5 2522 1 .OO 5250 1 .OO 1 .OO 
A comparison of the thermally induced increase in radiation sensitivity of C3H mammary 
tumors and normal mouse skin. T.E.R. (Thermal Enhancement Ratio) is defined here as the ratio 
of the dose required to produce 50 percent response at 37.S°C to the dose required to elicit 
the same response at a specified elevated temperature. 
TABLE 3. 
TEMP ANOXIC OXYGENATED O.E.R. 
("C) 
37.5 0.385 + .022 0.947 + .046 2.46 r .18 
41 .O 0.406 + .017 1 .I6 + .09 2.86 2 .25 
42.0 0.68 + .06 1.86 + .017 2.72 r .35 
42.5 1.07 + .06 1.81 + .18 1.69 t .14 
43.0 1.93 + .09 2.66 + .12 1.38 r .09 
43.5 2.24 + . I  7 2.09 + .33 0.87 r .16 
The differential effect of hyperthermia on anoxic and oxygenated mouse bone marrow cells. The 
main body of the table gives slopes of both anoxic and well-oxygenated cells in units of 1 ~ - ~ : r a d .  
Treatment times were for one hour except for the highest treatment temperature. 43.5%. for which a 
shorter time of 20 minutes was used. The O.E.R. values were calculated from the ratio of survival 
curve slopes. 
TABLE 4 .  
COMPARATIVE DATA O N  STAGE IIIA 
METASTATIC MELANOMA O F  T H E  EXTREMITIES 
No Iieat Heat 
(1951-65) (1957-74) 
Number of patients.. . . .  27 30 
. . . . . . . . . . . . .  Female 13 24 
Male . . . . . . . . . . . . . . .  14 6 
Extremity involved 
. . . . . . . . . . . . .  Upper. 7 2 
Lower. . . . . . . . . . . . . .  20 28 
Regional nodes proved 
negative 
microscopically. . . . . .  22/27, 81 % 17/30, 56% 
Patients with more than 
one recurrent (meta- 
. . . . . . .  static) nodule. 21,78% 23,77% 
Radical amputation. . . .  8/27, 30% 0 
Patients perfused . . . . . . .  2 1 /27, 78 % 30/30, 100% 
. . . . . . .  Perfusion drug. .  Alkeran Alkeran 
Average dose 
. . . .  Lower extremity, 1.2-1.6 mgm./kqm. 0.9 mgm./kgm. 
Perfusion time.. . . . . . . .  45-120 mins. 45-120 mins. 
Skin temperature. . . . . .  86-90°F. 102-105°F. 
Muscle temperature. . . .  92-9S°F. 102-104°F. 
Five year survival rate 
Males and females.. .. 22.2%* 76.7%t 
Females only. . . . . . . .  13, 30.7 yo* 24, 88.7%1 
'Crude. 
tBerkson-Gage. 
Figure  1. 
HYPERTHERMIA. man o 1 4 5 ~ ~  
DOSE, r o d s  
Fract.iona1 survival (corrected for cellular multiplicity) of cells heated for various times 
at 46°C (upper curve, @) or X rays (lower curve, m). In this and the following figures curves 
were fitted to the data points by eye. Standard errors were smaller than the plotted points. 
Figure  2. 
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Figure 3. 
The percentage of surviving melanoma cells and fetal melano- 
" 
as a function of the duration of exposure to 43'(mean t S.O. of pooled HOURS AT 43. 
iments given). Data from Table 1. At 4 and 8 hr, the difference in heat The percentage of surviving colon carcinoma cells and fetal 
ivity barreen leal melanocytes and melanoma cells is statistically Intestinal cells as a function of the duration of exposure to 4 T  (mean 2 S.D. 
icant, p < 0.05 and p < 0.01, respectively. of pooled experiments given). Data from Table 2. At 2 and 4 hr, the dilfemnca 
in heat Mnsitivity between fetal intestinal cells end Colon carcinomb cells is 
statistically significant (p < 0.01). 
Figure  4. 
TIME (h) DOSE BLEOMYCIN (uglml) 
Effect of elevated temperature on the killing of 
V-79 Chinese hamster cells by thio-tepa (1 ). 
Effect of elevated temperature on the killing of 
HA1 Chinese hamster cells by bleomych (6). 
Figure 5. 
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Figure 6. 
THERAPEUTIC RATIO (T. R. 
Effect on Turnor 











Approxlnutr range of Intrml body temperatures 
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(--Resistance) 
TUMOUR 
Promotion of Inadequate heating 
favourable 'soil' I\ ;,*; do' Resistance to heat 






Host-tumor-therapy triad interrelationships 
govern therapeutic outcome. The possible hazards 
involving the host and the tumor when heat con- 
stitutes the treatment are indicated; 'potentiators' of 
heat (broken arrow) are viewed as affecting both 
these components. 
Figure  9. 
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DEPRESSION STlMU LATION 
Scheme to illustrate the difference in results ob- 
tained in treatment of the VX2 carcinoma by local 
heating and total body heating in terms of postulated 
effects on the host immune system. 
Figure  10. 
Total body hewing 
Weeks 
Regression lines fitted to log tumor volume measurements 
from the 7th week following tumor inoculation. Local hyperthermia to 
the tumor-bearing limb (A), or total-body hyperthermia (B), was 
applied on Days 35, 36, and 37 after cell inoculation. The individual 
tumor volumes for all experiments shown in Chart 3 have been plotted, 
and the equation to the regression line in each case is given. 
F igure 11. 
Questions an'd Answers Following Baker's Paper 
Singh: Why d i d  you not  go beyond 43O C? 
Baker: That l a s t  study was not  my p a r t i c u l a r  study; bu t  t h e  reason f o r  n o t  
0 going beyond 43 C is t h a t  a s  you s t a r t  t o  increase  the  temperature i n  
0 
excess of 43 C,  you begin t o  g e t  c e l l  k i l l i n g  and you l o s e  t h e  s e n s i t i z i n g  
e f f e c t  of  t h e  r ad ia t ion .  The idea  of t h e  r a d i a t i o n  i s  t o  increase  the  max- 
imum p o t e n t i a l  very quickly.  A t  higher temperatures you do not  need radia-  
t i o n ;  you k i l l  a l l  the  c e l l s  without  it. 
Merz: What were t h e  drugs? 
Baker: The drugs were cyclophosphamide and adriamycin. 
Merz: What were t h e  two before? 
Baker: The two before  were bleomycin and thio-tepa.  
Singh: D r .  Baker, how i s  the  heat ing  done i n  t h e  s t u d i e s  by D r .  Holt ,  f o r  
example? 
Baker: D r .  Holt uses  a c i r c u l a r  a r r a y  of some 12 radio-frequency genera tors  
opera t ing  a t  414 megahertz. This r a d i o  frequency w i l l  hea t  a very lq rge  
volume of t i s s u e .  The frequency i s  r e a d i l y  absorbed so  t h a t  t h e r e  i s  very 
e f f e c t i v e  heat ing.  D r .  Pet t igrew uses  a l i q u i d  molten p a r a f f i n  ba th .  H e  
bags t h e  p a t i e n t  i n  a p l a s t i c  bag, in tuba tes  him, and uses sp ina l  anesthe- 
s i a .  He depends on t h e  h e a t  of fus ion of t h e  p a r a f f i n  a s  it goes from t h e  
l i q u i d  t o  the  s o l i d  s t a t e ,  i n  o rde r  t o  produce t h e  proper temperature t o  
h e a t  t h e  p a t i e n t .  H i s  p a t i e n t s  a r e  kep t  under these  condi t ions  f o r  6 t o  14 
hours, so it is a simple system. The German group uses  in f ra red  r a d i a t i o n  
f o r  t h e i r  t o t a l  body hyperthermia. The group i n  Colombia a t  Bogota uses 
Coley's tox in ,  o r  i t s  l o c a l  equivalent ,  f o r  inducing systemic hyperthermia. 
Other groups use d i f f e r e n t  frequencies of r a d i a t i o n  f o r  l o c a l  hyperthermia. 
The RTOG protocol  c a l l s  f o r  the  use  of 915 megahertz. W e  have t r i e d  both 
2450 megahertz, and more recen t ly  27 megahertz, r a d i a t i o n  f o r  inducing 
l o c a l  hyperthermia. 
E. Long: I d i d  n o t  ca tch ,  and perhaps you had it t h e r e ,  t h e  amount of time 
t h a t  l o c a l l y  it was heated,  o r  sys temical ly  it was heated,  ve r sus  t h e  
amount of time f o r  t h e  X-ray rad ia t ion .  
Baker: It t u r n s  o u t  t h a t  a s  long a s  you a r e  i n  a temperature range between 
0 0 41 C and 43 C t h e  e f fec t iveness  of  your thermal enhancement -- o r  i f  you 
l i k e ,  the thermal enhancement r a t i o  -- i s  d i r e c t l y  r e l a t e d  t o  the  dura t ion .  
0 So you would, i f  you have a 41 C hyperthermia, l i k e  t o  s u s t a i n  it f o r  a s  
long a s  you could. In  t h i s  circumstance w e  a r e  t a l k i n g  about some 3 ,  4,  5,  
o r  more hours. On t h e  o the r  hand, i f  you can g e t  t o  a temperature of 
0 
around 43 C,  then probably 1 t o  2 hours w i l l  g ive  you t h e  maximum 
the rapeu t i c  r a t i o .  
E. Long: How does t h a t  compare-to t h e  length  of time f o r  t h e  X-rays? 
Baker: W e l l ,  t h e  X-rays a r e  conventionally de l ivered  a t  conventional dose 
r a t e s  of  perhaps 100 t o  250 rads  per  minute. I f  your f r a c t i o n  s i z e  is  a s  
we have usual ly  used, somewhere between 300 and 500 rads  per  f r a c t i o n ,  then 
t h e  dura t ion  of your r a d i a t i o n  would be somewhere between 3 and 5 m i n u t e s .  
Yes, D r .  Atkinson. 
Atkinson: Don, when I came i n ,  you had a s l i d e  up of  the rapeu t i c  r a t i o s ;  
and I d i d  n o t  q u i t e  g e t  t h e  s t o r y  t h a t  went wi th  them. Was t h a t  on i n  
v i t r o  o r  i n  vivo measurements? How was it measured? 
Baker: I a m  no t  sure  which s l i d e  we were t a l k i n g  about. I th ink t h i s  was 
an i n  vivo mouse mammary carcinoma system. 
Atkinson: How was t h e  damage t o  t h e  normal t i s s u e  measured? 
Baker: I understand, yes. This was t h e  damage done t o  t h e  skin .  This was 
a sk in  r e a c t i o n  graded 1, 2, 3, e t c . ,  compared t o  l o c a l  con t ro l  of t h e  mam- 
mary tumor. This was t h e  r a t i o .  
Singh: The temperatures t h a t  you a r e  t a l k i n g  about a r e  the  e n t i r e  mouse 
temperatures. They a r e  n o t  t h e  temperatures of t h e  regisi i  you a r e  t r e a t i n g .  
Is t h a t  r i g h t ?  
Baker: Well, i n  some of t h e  work I was r e f e r r i n g  t o ,  we were t a l k i n g  about 
systemic hyperthermia and t h e  temperature of t h e  whole body. I n  o the r  
cases ,  it was l o c a l  hyperthermia and t h e  temperature of t h e  tumor, o r  t h e  
volume t h a t  you a r e  p a r t i c u l a r l y  concerned with r ad ia t ing .  
Singh: And t h a t  was t h a t  low f o r  t h i s  t reatment? It d i d  no t  go higher? 
Baker: No, no. Once you g e t  higher than about 43O C ,  you begin t o  produce 
such an inc rease  i n  s e n s i t i v i t y  of t h e  normal t i s s u e s  t h a t  your therapeut ic  
r a t i o  i s  l o s t  and the re  i s  no advantage. 
Beebe: I n  these ,  d id  you measure t h e  temperature of t h e  tumor and of t h e  
t i s s u e  separa te ly?  
Baker: Y e s .  That is the  way t h a t  we always t r y  t o  do it. There a r e  some 
considerable d i f f i c u l t i e s  with making t h a t  measurement, a s  you can well  
imagine,because the re  a r e  l o c a l  a r e a s  where t h e r e  i s  c i r c u l a t i o n ,  and f o r  
o the r  t echn ica l  reasons and physio logica l  reasons,  t h e r e  a r e  temperature 
g rad ien t s  t h a t  e x i s t .  
Rosato: D r .  Baker, t h e  incidence of  cancer i n  undescended t e s t e s  i s  known 
t o  be seven- o r  e ight - fo ld  g r e a t e r  than the  normal s i t u a t i o n .  The assump- 
t i o n  unproven i s  t h a t  t h i s  i s  t h e  r e s u l t  of t h e  exposure of t h e  t e s t i c l e  t o  
a higher temperature over a longer per iod  o f  time i n  i t s  intra-abdominal 
posi t ion.  Is there any l i t e r a t u r e ,  o r  any caveats, about the  possible 
carcinogenic e f f e c t  of hyperthermia, especial ly  when applied over a long 
period of time? 
Baker: No .  This is information we do not have, but  there  a r e  a couple of 
s tud ies  i n  which t h i s  i s  addressed ind i rec t ly .  I f  you take.an animal, a 
r a t  fo r  example, and place him i n  a chronic, low temperature, 3 o r  4 
degrees above freezing,  he compensates f o r  t h i s  by increasing h i s  metabolic 
r a t e .  In  f a c t ,  he w i l l  double it. He w i l l  l i v e  h i s  whole l i f e  a t  twice 
i t s  normal r a t e .  Not only t h a t ,  but he w i l l  compensate by increasing h i s  
core body temperature. H i s  core body temperature w i l l  go up about 2 
degrees, so now you have an animal whose core temperature i s  up 2 degrees, 
and it i s  up 2 degrees f o r  the  r e s t  of h i s  l i f e .  Now, the  incidence of 
tumors i n  those animals i s  dramatically l e s s ,  not more, so  t h a t  t h i s  Leaves 
the  question s t i l l  very much unanswered. But t h a t  i s  about the  only com- 
parison I can make f o r  you. 
